Skip to main content
Signal8

CS DIAGNOSTICS CORP. (CSDX)

Headquartered in Neuss, Germany, CS Diagnostics Corp. was established in 1996. The company is dedicated to the development, production, and worldwide distribution of a range of health and medical-grade products, catering to both domestic German and international markets. Among its key offerings are MEDUSA, an exclusive surface disinfectant, and CS-Protect Hydrogel, a specialized tissue-spacing gel for radiation therapy applications. The firm rebranded as CS Diagnostics Corp. in August 2023, having previously operated under the name FlashZero Corp.

Sector: Specialty Cleaning, Polishing and Sanitation Preparations

Industry: Medical - Devices

CS Diagnostics Corp. logo

CS Diagnostics Corp.

OTC:CSDXHealthcare
Mkt Cap$1M
Float137.28M
O/S137.34M
Inst Own-
SI<0.1%
Dilution
FormDescription
8-K
NT 10-Q
SEC Filing
3
10-K
Annual Report
NT 10-K
SEC Filing
10-12G/A
AMENDMENT NO. 3
3
PRIMARY DOCUMENT
3
PRIMARY DOCUMENT
3
PRIMARY DOCUMENT
10-12G/A
AMENDMENT NO. 2
10-Q
Quarterly Report
8-K
8.01,9.01
10-Q
Quarterly Report
13G
Beneficial Ownership Report
13G
Beneficial Ownership Report
10-12G/A
AMENDMENT NO. 1
10-12G
SEC Filing
RW
SEC Filing
10-12G
SEC Filing
8-K
8.01
10-Q
QUARTERLY REPORT
10-K
ANNUAL REPORT
10-Q
QUARTERLY REPORT
10-Q
QUARTERLY REPORT
10-Q
QUARTERLY REPORT
10-K
ANNUAL REPORT

1-25 of 146

…